Article
Heidelberg Engineering GmbH has been granted FDA clearance for a module that enhances its proprietary spectral-domain optical coherence tomography (OCT) platform by providing a detailed, multi-modality view of the anterior segment (Spectralis Anterior Segment Module).
Heidelberg, Germany-Heidelberg Engineering GmbH has been granted FDA clearance for a module that enhances its proprietary spectral-domain optical coherence tomography (OCT) platform by providing a detailed, multi-modality view of the anterior segment (Spectralis Anterior Segment Module).
The module, which consists of an add-on lens and dedicated software, allows for simultaneous confocal scanning laser ophthalmoscopy and OCT imaging. It is compatible with all models of the proprietary OCT platform.
The module provides high-resolution images of cornea, anterior chamber angle, and sclera. Clinicians can assess both chamber angles at the same time using a 16-mm wide angle-to-angle OCT scan.
“[This module] paves the way towards digital gonioscopy,” said Sanjay Asrani, MD, associate professor of ophthalmology, Duke University Eye Center. “Glaucoma surgeons will further benefit from the enhanced depth imaging OCT capabilities of [the proprietary OCT platform] when assessing filtering blebs and anterior chamber angles.”
For more articles in this issue of Ophthalmology Times eReport, click here.